Enforcement record
Criminal Accusation disclosure naming ノバルティス ファーマ株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Criminal Accusation
Law
Pharmaceutical Affairs Act
Authority
Ministry of Health, Labour and Welfare
Action date
9 January 2014
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Jul 12, 2026, 03:14 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Action summary
- Company
- ノバルティス ファーマ株式会社Japanese onlyOriginal: ノバルティス ファーマ株式会社
- Governing law
- Pharmaceutical Affairs Act薬事法
- Action type
- Criminal Accusation告発
- Action date
- 9 January 2014
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品広告
Violation
Novartis Pharma K.K. used materials that described the results of clinical studies, the 'JIKEI HEART Study' conducted at Tokyo Jikei Medical University and the 'KYOTO HEART Study' conducted at Kyoto Prefectural University of Medicine, to advertise the efficacy or effects of the drug Diovan tablets. These advertisements were made using the results of these clinical studies.
Show original Japanese text
ノバルティス ファーマ株式会社は、平成23年から平成24年にかけて、ディオバン錠に係る東京慈恵会医科大学において実施された臨床研究である「JIKEI HEART Study」及び京都府立医科大学において実施された臨床研究である「KYOTO HEART Study」の結果を記載した資材を用いて、同医薬品の効能又は効果に関して広告を行った。
Public documents and saved materials
View official publications and the available saved materials. Purchase a one-time evidence pack to download the compiled files.
Loading materials…
Compliance context
HighThe authority announced a criminal accusation or referral based on the disclosed facts.
Japanese regulatory disclosure under Pharmaceutical Affairs Act.
Escalate for legal review and check whether later public records changed the status of the matter.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.